r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

JC

Jon Congleton

Insider · Chief Executive Officer · MLYS

Jon Congleton files insider transactions with the SEC as a chief executive officer of Mineralys Therapeutics (MLYS). We hold 5 disclosed purchases and sales filed since 15 September 2015, 2 of them in the last 90 days.

  • Files forMLYS
  • Disclosed buys and sells5 in all, 2 in the last 90 days
  • Last disclosure15 July 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 9 February 2023 — 13 July 2026Chief Executive Officer · Mineralys Therapeutics (MLYS)44 Form 4 lines · source: SEC Form 4
  • Filed 29 June 2026 — 5 July 2026Director · Immunic (IMUX)2 Form 4 lines · source: SEC Form 4
  • Filed 29 April 2026 — 29 April 2026Director · Avalyn Pharma (AVLN)1 Form 4 line · source: SEC Form 4
  • Filed 11 September 2015 — 12 September 2016President and CEO · Nivalis Therapeutics (NVLS)6 Form 4 lines · source: SEC Form 4

Everything they disclosed

53 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.